Identification of high-performing antibodies for tyrosine-protein kinase SYK for use in Western Blot, immunoprecipitation and immunofluorescence
F1000Research · 2024
DOI: 10.12688/f1000research.140456.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2024. Verfasst von Walaa Alshafie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H…. Hauptthemen laut MEDLINE: Syk Kinase, Immunoprecipitation, Blotting, Western, Fluorescent Antibody Technique. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging, Genome Canada.
Abstract (Originalsprache)
Tyrosine-protein kinase SYK, encoded by the SYK gene, is a non-receptor type protein kinase which mediates immune signal transduction through immunoreceptors. Tyrosine-protein kinase SYK expression has been associated with the development of various inflammatory diseases, cancer and neurodegenerative conditions. The reproducibility of tyrosine-protein kinase SYK research would help elucidate the mechanism in which it causes neuroinflammation as well as its potential as a novel target to treat Alzheimer’s disease. This would be facilitated with the availability of high-quality tyrosine-protein kinase SYK. In this study, we characterized thirteen tyrosine-protein kinase SYK commercial antibodies for Western Blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. We identified many high-performing antibodies and encourage readers to use this report as a guide to select the most appropriate antibody for their specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.
ORCID-Profile: Kathleen Southern, Carl Laflamme
Förderung
- NIA NIH HHS
- National Institute on Aging
- Genome Canada
- Mitacs
- Ontario Genomics
- Canadian Institutes of Health Research Foundation
- Genome Quebec
Zitieren
APA
Alshafie, W., Fotouhi, M., Ayoubi, R., Southern, K., Laflamme, C., & NeuroSGC/YCharOS collaborative group (2024). Identification of high-performing antibodies for tyrosine-protein kinase SYK for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Research. https://doi.org/10.12688/f1000research.140456.3
Vancouver
Alshafie W, Fotouhi M, Ayoubi R, Southern K, Laflamme C, NeuroSGC/YCharOS collaborative group. Identification of high-performing antibodies for tyrosine-protein kinase SYK for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Research. 2024. doi:10.12688/f1000research.140456.3
BibTeX
@article{Alshafie2024,
author = {Alshafie, Walaa and Fotouhi, Maryam and Ayoubi, Riham and Southern, Kathleen and Laflamme, Carl and NeuroSGC/YCharOS collaborative group, NeuroSGC/YCharOS collaborative group},
title = {Identification of high-performing antibodies for tyrosine-protein kinase SYK for use in Western Blot, immunoprecipitation and immunofluorescence},
journal = {F1000Research},
year = {2024},
doi = {10.12688/f1000research.140456.3}
}
EUVIMED